Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)

Saved in:
Bibliographic Details
Main Authors: Seyed Alireza Mirhosseini, Mohammadreza Akbari, Davar Aldavood, Hooyar Zarifkar, Armin Attar, Javad Kojuri
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12266445/?tool=EBI
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839625046024257536
author Seyed Alireza Mirhosseini
Mohammadreza Akbari
Davar Aldavood
Hooyar Zarifkar
Armin Attar
Javad Kojuri
author_facet Seyed Alireza Mirhosseini
Mohammadreza Akbari
Davar Aldavood
Hooyar Zarifkar
Armin Attar
Javad Kojuri
author_sort Seyed Alireza Mirhosseini
collection DOAJ
format Article
id doaj-art-396d02dc86954ccc9080bb4f19b51128
institution Matheson Library
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-396d02dc86954ccc9080bb4f19b511282025-07-18T05:31:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)Seyed Alireza MirhosseiniMohammadreza AkbariDavar AldavoodHooyar ZarifkarArmin AttarJavad Kojurihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC12266445/?tool=EBI
spellingShingle Seyed Alireza Mirhosseini
Mohammadreza Akbari
Davar Aldavood
Hooyar Zarifkar
Armin Attar
Javad Kojuri
Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)
PLoS ONE
title Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)
title_full Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)
title_fullStr Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)
title_full_unstemmed Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)
title_short Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol)
title_sort rationale and design of randomized non inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention ticalone taha10 protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12266445/?tool=EBI
work_keys_str_mv AT seyedalirezamirhosseini rationaleanddesignofrandomizednoninferiorityclinicaltrialtocomparethesafetyandefficacyofticagrelormonotherapywithdualantiplatelettherapyinchroniccoronarysyndromepatientspostpercutaneouscoronaryinterventionticalonetaha10protocol
AT mohammadrezaakbari rationaleanddesignofrandomizednoninferiorityclinicaltrialtocomparethesafetyandefficacyofticagrelormonotherapywithdualantiplatelettherapyinchroniccoronarysyndromepatientspostpercutaneouscoronaryinterventionticalonetaha10protocol
AT davaraldavood rationaleanddesignofrandomizednoninferiorityclinicaltrialtocomparethesafetyandefficacyofticagrelormonotherapywithdualantiplatelettherapyinchroniccoronarysyndromepatientspostpercutaneouscoronaryinterventionticalonetaha10protocol
AT hooyarzarifkar rationaleanddesignofrandomizednoninferiorityclinicaltrialtocomparethesafetyandefficacyofticagrelormonotherapywithdualantiplatelettherapyinchroniccoronarysyndromepatientspostpercutaneouscoronaryinterventionticalonetaha10protocol
AT arminattar rationaleanddesignofrandomizednoninferiorityclinicaltrialtocomparethesafetyandefficacyofticagrelormonotherapywithdualantiplatelettherapyinchroniccoronarysyndromepatientspostpercutaneouscoronaryinterventionticalonetaha10protocol
AT javadkojuri rationaleanddesignofrandomizednoninferiorityclinicaltrialtocomparethesafetyandefficacyofticagrelormonotherapywithdualantiplatelettherapyinchroniccoronarysyndromepatientspostpercutaneouscoronaryinterventionticalonetaha10protocol